IceCure Medical Ltd. (ICCM) Form 6-K — Oct 5, 2026

IceCure Medical disclosed that the AMA's CPT Editorial Panel determined on October 2, 2026 that a transition to a permanent Category I CPT code for breast cryoablation with the ProSense system is premature and did not approve the request. The temporary Category III code remains in place, allowing facilities to be paid approximately $4,000 in facility fees by CMS, so the company's commercial activities and reimbursement framework are unaffected for now.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.